Article Text

other Versions

PDF
Cost effectiveness analysis
Hammering the point home: serologic testing costs more and harms more patients than other strategies for the diagnosis of active tuberculosis in India
  1. Dick Menzies
  1. Department of Respiratory and Epidemioplogy, Montreal Chest, Montreal, Canada
  1. Correspondence to Dick Menzies
    Department of Respiratory and Epidemiology, Montreal Chest, 3650 St. Urbain, Montreal, QC H2X2P4, Canada; dick.menzies{at}mcgill.ca

Statistics from Altmetric.com

Commentary on:

Context

A rapid and accurate, yet inexpensive test to diagnose active pulmonary tuberculosis (TB) would increase detection of cases, and might diagnose patients at an earlier stage of disease reducing morbidity and mortality, as well as transmission. Currently the most widely used rapid test is acid fast bacilli (AFB) smear microscopy. AFB smears are inexpensive, and can provide results within hours. However, they are insensitive, detecting approximately half of all pulmonary TB cases, albeit those who are sicker and more contagious with more advanced disease. TB cultures are considered the gold standard for diagnosis but are more expensive and complex, and only provide results after weeks to …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.